CAPTRUST Financial Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Sell |
150,316
-1,989
| -1% | -$139K | 0.02% | 452 |
|
|
2025
Q1 | $11.2M | Buy |
152,305
+32,615
| +27% | +$2.4M | 0.03% | 403 |
|
|
2024
Q4 | $7.84M | Sell |
119,690
-17,443
| -13% | -$1.14M | 0.02% | 425 |
|
|
2024
Q3 | $10.7M | Sell |
137,133
-8,001
| -6% | -$623K | 0.03% | 365 |
|
|
2024
Q2 | $11.3M | Buy |
145,134
+18,786
| +15% | +$1.47M | 0.04% | 332 |
|
|
2024
Q1 | $8.56M | Buy |
126,348
+3,544
| +3% | +$240K | 0.03% | 372 |
|
|
2023
Q4 | $8.27M | Buy |
122,804
+4,984
| +4% | +$336K | 0.03% | 408 |
|
|
2023
Q3 | $7.98M | Buy |
117,820
+4,936
| +4% | +$334K | 0.03% | 381 |
|
|
2023
Q2 | $8.08M | Sell |
112,884
-4,456
| -4% | -$319K | 0.03% | 372 |
|
|
2023
Q1 | $8.14M | Buy |
117,340
+7,703
| +7% | +$535K | 0.04% | 334 |
|
|
2022
Q4 | $7.43M | Buy |
109,637
+10,819
| +11% | +$734K | 0.04% | 349 |
|
|
2022
Q3 | $5.42M | Buy |
98,818
+35,111
| +55% | +$1.93M | 0.03% | 378 |
|
|
2022
Q2 | $4.21M | Buy |
63,707
+3,354
| +6% | +$222K | 0.03% | 407 |
|
|
2022
Q1 | $4M | Buy |
60,353
+6,954
| +13% | +$461K | 0.03% | 412 |
|
|
2021
Q4 | $3.11M | Buy |
53,399
+2,082
| +4% | +$121K | 0.02% | 460 |
|
|
2021
Q3 | $3.08M | Buy |
51,317
+19,050
| +59% | +$1.14M | 0.03% | 423 |
|
|
2021
Q2 | $1.93M | Sell |
32,267
-1,104
| -3% | -$66.1K | 0.02% | 513 |
|
|
2021
Q1 | $1.66M | Sell |
33,371
-275
| -0.8% | -$13.7K | 0.02% | 515 |
|
|
2020
Q4 | $1.68M | Sell |
33,646
-7,919
| -19% | -$396K | 0.02% | 452 |
|
|
2020
Q3 | $2.26M | Buy |
41,565
+935
| +2% | +$50.8K | 0.04% | 332 |
|
|
2020
Q2 | $2.17M | Buy |
40,630
+3,375
| +9% | +$180K | 0.04% | 333 |
|
|
2020
Q1 | $1.63M | Sell |
37,255
-648
| -2% | -$28.4K | 0.04% | 331 |
|
|
2019
Q4 | $1.91M | Buy |
+37,903
| New | +$1.91M | 0.03% | 376 |
|